Blacksmith Brands Inc.
Industry
- Pharmaceuticals
- OTC, Consumer
Latest on Blacksmith Brands Inc.
Prestige Brands Holdings Inc. is responsible to correct information in FDA's National Drug Code Directory for two products in a line it sold a year ago, the PediaCare OTC allergy and cough/cold br
Prestige Brands Holdings Inc. could spend as much as $1 billion on its next brand acquisition, roughly equal to the firm’s OTC buying spree over the past four years, says CEO Matthew Mannelly. “Toda
Prestige Brands Holdings Inc. could spend as much as $1 billion on its next brand acquisition, roughly equal to the firm’s OTC buying spree over the past four years, says CEO Matthew Mannelly. “Toda
Prestige Brands Holdings Inc. could spend as much as $1 billion on its next brand acquisition, roughly equal to the firm’s OTC buying spree over the past four years, says CEO Matthew Mannelly. “Toda